Seller transaction history
Sanofi S.A. (Retaining 48.2% Stake alongside Bpifrance 1.8%) exits & divestitures
Explore transactions involving Sanofi S.A. (Retaining 48.2% Stake alongside Bpifrance 1.8%) as the recorded seller. Compare the businesses sold, buyers, transaction dates and available valuation data, then open each comp to review its sources and deal structure.
Coverage includes published FundComb transactions recorded under Sanofi S.A. (Retaining 48.2% Stake alongside Bpifrance 1.8%). Subsidiaries, other names and undisclosed activity may be recorded separately.
- Reviewed transactions
- 1
- With value data
- 1
- With revenue multiples
- 1
- Transaction years
- 2024
Sortable transaction comps
Sanofi S.A. (Retaining 48.2% Stake alongside Bpifrance 1.8%) transaction table
Rows with reported value
1 / 1
Acquisition EV, USD
USD 17B
Investment EV, USD
-
Median EV / revenue
3.1x
Selected comparison set
Saved in this browser only. Nothing is written to FundComb data.
Choose transactions from the table to build a quick comparison set.
1 shown of 1 matching transactions. Click any transaction row for more detail.
Values are 100% enterprise values. Multiples divide EV by full-company revenue or EBITDA. Reported prices are assumed to be EV; explicit partial-stake prices are grossed up as estimates. Amounts paid are tracked separately.
| Select for comparison | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Opella Control (50%) | 2024-10-21 | Clayton, Dubilier & Rice | EUR 16B Enterprise Value | 17,365 | 3.1x | 14.0x | France, United States & Global | Confirmed 1 source |
Explore related tags
Continue to the full transaction history for each tag.
Buyers in these transactions
Source coverage varies by transaction. Announced deals, minority investments and capital raises retain their own labels; an investment amount is separate from enterprise value. Read the methodology.